Structural Heart Devices Market Scope And Analysis

Report Code : TIPHE100001164
Category : Life Sciences

No. of Pages : 150

Buy Now

Structural Heart Market Scope, Analysis, and Trends by 2028

Buy Now

Structural Heart Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 14.25 Billion
Market Size by 2031	US$ 28.48 Billion
Global CAGR (2023 - 2031)	8.00%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Occluders Annuloplasty Rings Heart Valve Balloons By Procedure Heart Valve Stenosis Heart Valve Regurgitation Left Atrial Appendage Closure By End User Hospitals Ambulatory Surgical Centers Cardiac Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories Medtronic Plc Boston Scientific Corp Artivion Inc Edwards Lifesciences Corp Lepu Medical Technology Beijing Co Ltd Braile Biomedica Industry Commerce and Representations Ltd Aran Biomedical Teoranta Micro Interventional Devices Inc

Structural Heart Market News and Recent Developments

The structural heart market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the structural heart market are listed below:

Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). (Source: Medtronic, Press Release, February 2023)
Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart diseases. The acquisition means that Genesis will be able to add J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device for both aortic regurgitation and stenosis patients, to its product portfolio. This addition will greatly improve Group's ability to better meet the needs of patients, interventional cardiologists, and cardiac surgeons. (Source: Genesis MedTech Group, Press Release, February 2022)

Structural Heart Market Report Coverage and Deliverables

The “Structural Heart Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Structural heart market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Structural heart market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Structural heart market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the structural heart market
Detailed company profiles